CB
MRNA icon

Commerce Bank’s Moderna MRNA Stock Holding History

Commerce Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Buy
55,243
+6,735
+14% +$348K 0.02% 416
2026
Q1 		$2.46M Buy
48,508
+13,841
+40% +$646K 0.01% 486
2025
Q4 		$1.02M Buy
34,667
+2,312
+7% +$62.8K 0.01% 666
2025
Q3 		$836K Sell
32,355
-87,528
-73% -$2.44M ﹤0.01% 714
2025
Q2 		$3.31M Buy
+119,883
New +$3.16M 0.02% 394
2024
Q4 		– Sell
-9,471
Closed -$633K – 1214
2024
Q3 		$633K Buy
9,471
+787
+9% +$72.3K ﹤0.01% 788
2024
Q2 		$1.03M Sell
8,684
-18
-0.2% -$2.28K 0.01% 617
2024
Q1 		$927K Buy
8,702
+3,441
+65% +$347K 0.01% 645
2023
Q4 		$523K Sell
5,261
-326
-6% -$27.4K ﹤0.01% 835
2023
Q3 		$577K Sell
5,587
-92
-2% -$10.3K ﹤0.01% 753
2023
Q2 		$690K Sell
5,679
-1,174
-17% -$157K 0.01% 688
2023
Q1 		$1.05M Sell
6,853
-9,113
-57% -$1.5M 0.01% 553
2022
Q4 		$2.87M Buy
15,966
+9,757
+157% +$1.6M 0.02% 383
2022
Q3 		$734K Buy
6,209
+1,180
+23% +$179K 0.01% 630
2022
Q2 		$718K Sell
5,029
-2,249
-31% -$321K 0.01% 637
2022
Q1 		$1.25M Sell
7,278
-277
-4% -$46.6K 0.01% 551
2021
Q4 		$1.92M Sell
7,555
-36,660
-83% -$10.7M 0.01% 475
2021
Q3 		$17M Sell
44,215
-1,002
-2% -$370K 0.12% 149
2021
Q2 		$10.6M Buy
45,217
+176
+0.4% +$31.5K 0.08% 197
2021
Q1 		$5.9M Buy
45,041
+38,953
+640% +$5.64M 0.04% 272
2020
Q4 		$636K Buy
6,088
+852
+16% +$86.2K 0.01% 693
2020
Q3 		$370K Buy
5,236
+725
+16% +$50.5K ﹤0.01% 787
2020
Q2 		$290K Buy
+4,511
New +$247K ﹤0.01% 851

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Commerce Bank's MRNA Position: Q2 2026 in Review

Commerce Bank increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $348K and bringing the position to 55,243 shares worth $3.87M. The position accounts for 0.02% of the portfolio, ranked #416.

Commerce Bank first reported a position in MRNA in Q2 2020 and has held it in 23 quarters since. The position peaked at $17M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Commerce Bank held 55,243 shares of Moderna worth $3.87M as of Q2 2026.
  • Commerce Bank bought 6,735 Moderna shares in Q2 2026, an estimated $348K.
  • Moderna made up 0.02% of Commerce Bank's portfolio in Q2 2026, its #416 holding.
  • Commerce Bank first reported a position in Moderna in Q2 2020 and has held it in 23 quarters since.
  • Commerce Bank's Moderna position peaked at $17M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.